Alopecia Market – By Disease Type, By Treatment Type, By Gender, By Sales Channel, By End Use - Global Forecast, 2024 – 2032

Alopecia Market Size

The global alopecia market size was valued at around USD 8.7 billion in 2023 and is estimated to grow at 8.1% CAGR from 2024 to 2032. The expansion of the market is fueled by the growing incidence of alopecia and the emerging concern around available treatment options. The increase in health conditions has been attributed to genetic factors, hormonal imbalance, autoimmune diseases, environmental factors, and even lifestyle factors that include poor diet and stress.
 

For instance, in the U.S. alone, an estimated 6.8 million people suffer from alopecia areata, and the numbers keep increasing. This boom in the patient base is increasing the requirement for pharmaceuticals, hair restoration products, and advanced hair transplant procedures. According to the National Alopecia Areata Foundation, there is a shift in the value offering along with significant improvements in the accuracy of diagnostics, hair implants, and laser therapy, which has made treatment options more cost-effective and easier to access.

Moreover, in a bid to combat hair loss, many people are starting to recognize the advertising potential of social channels and moving away from traditional marketing strategies, which will help them quickly increase their market share. Social media, combined with the newfound availability of pharmaceuticals, laser therapy devices, hair implants, and especially the advertising of new therapies, makes it increasingly likely that more people would opt for treatments, thereby increasing the market potential.
 

Due to this explosion in the use of social media for marketing, more people become aware of treatment options, which greatly increases the number of people who would seek treatment, further increasing the demand.
 

Alopecia is a type of hair loss condition affecting the scalp, face, or other regions of the body. Some of its causes include age, family history, hormone changes, and autoimmune diseases. There can be multiple forms of alopecia with hair loss of different patterns, and it can be chronic or acute.
 

Alopecia Market Trends

• Developments in the treatment of alopecia have changed the industry for the better, for there are more diverse and newly formulated products to help with hair loss. Innovation in the field leads to new drugs, devices, and therapies that are enabling the rapid growth in the treatment of alopecia, leading the market to grow at an astonishing rate.
   
• Drugs such as JAK inhibitors and other types are helping with hair loss in autoimmune conditions such as alopecia areata by biologically impacting the immune structures responsible for hair loss. Moreover, the development of more advanced biologics now allows for specific treatment.
   
• Moreover, in combination with the previously mentioned methods, Platelet-Rich Plasma (PRP) therapy is also used where a scalp is injected with the patient's blood plasma, which has many growth factors in them to stimulate hair follicles. This treatment is becoming popular because it is minimally invasive and more natural.
   
• Additionally, studies are being done on stem cell therapies that focus on promoting hair follicle regeneration. Stem cell-based treatments are still in their infancy, but they can transform how alopecia is treated. These technological innovations created new opportunities for additional treatments, enhanced patients' benefits, and stimulated important development in the alopecia industry.
   

Alopecia Market Analysis

Based on disease type, the market is classified into androgenetic alopecia, alopecia areata, and other disease types. The androgenetic alopecia segment generated the highest revenue of USD 4.8 billion in 2023.
 

• A considerable number of people are considered balding with Androgenetic Alopecia, also referred to as male or female pattern baldness. Androgenetic alopecia affects roughly 30-50% of the male population over the age of 50 years, and this data from National Institutes of Health makes it evident how common this condition is. That acclaim makes this part of the market the strongest.
   
• Moreover, there is a range of easy treatment options available for those diagnosed with Androgenetic Alopecia. These include Minoxidil solution, oral Finasteride, as well as hair transplant surgery. All of these have been clinically approved and therefore have much higher acceptance rates from patients, allowing greater expansion of this segment of the market.
   

Based on treatment type, the alopecia market is categorized into pharmaceuticals, devices, and other treatments. The pharmaceuticals segment dominated the market by obtaining 48.8% of market share in 2023.
 

• Topical and oral medications serve as a first resort for treating several types of alopecia. These medications are easy to use, effective, and allow hair to grow, giving them ideal access, which makes them the preferred treatment option.
   
• Moreover, they tend to be cheaper than devices and other therapies, which explains high acceptability. Many of these drugs are FDA approved and supported by considerable clinical research, therefore making them safe and effective, further boosting their market adoption.
   

Based on gender, the alopecia market is categorized into male and female. The male segment is anticipated to dominate the market by obtaining USD 11.6 billion in 2032.
 

• Male pattern baldness or androgenetic alopecia is very common in men compared to women. Studies indicate that close to 50% of men suffer from significant hair loss by their 50s, which substantially increases demand in the market for alopecia treatments.
   
• Additionally, women tend to suffer hair loss at a slower pace compared to men. Because of this, men will start actively looking for treatments as early as possible. This results in a greater percentage of the male population seeking treatment.
   

Based on sales channel, the alopecia market is classified into prescription and OTC. The prescription segment is anticipated to grow at the fastest pace of CAGR 8.3% during the forecast period.
 

• With prescription medications for treating alopecia such as finasteride or specific corticosteroids, a patient is more likely to see results, unlike OTC ones which are generally less effective. This makes patients more willing to see doctors for prescriptions to get appropriate medications.
   
• Moreover, some forms of alopecia, such as androgenetic alopecia or advanced alopecia areata, necessitate strength of medication which can only be prescribed by a dermatologist, thus creating more demand for prescription medicines out of concern.
   

Based on end-use, the alopecia market is classified into dermatology clinics, homecare settings, and other end-users. The dermatology clinics segment generated the highest revenue of USD 4.6 billion in 2023.
 

• Professional dermatology clinics are equipped to assess and manage different types of hair loss, including alopecia. Their capabilities exceed those of self-care offices because, in addition to offering prescription medications, they also provide laser treatment and surgical hair transplants as part of hair restoration procedures.
   
• Furthermore, methods such as microneedling and other forms of PRP therapy, along with other prescription and non-prescription strength drugs, enable dermatologists to treat patients with greater effectiveness and higher chances of success, which compels more and more patients to visit clinics instead.
   

North America alopecia market accounted for USD 3.2 billion market revenue in 2023 and is anticipated to grow at CAGR of 7.7% between 2024 to 2032 period.
 

• In North America, one of the most common types of alopecia, especially androgenic alopecia, is very prevalent, which translates to an enormous number of people suffering from hair loss. The very high prevalence fuels the need for cosmetic solutions, which in turn drives growth in the market.
   
• In addition, the U.S. and Canada have well-established healthcare systems, so the introduction of new technologies such as pharmaceuticals, laser, and even surgical procedures are readily accepted. These aid the infrastructure of the market by fostering the dissemination of advanced techniques.
   

The U.S. held a dominant position in the alopecia market, with a revenue of USD 3.1 billion in 2023.
 

• The U.S. market for hair restoration technologies is greatly supported by the spending power of large corporations as well as strong demands for prescription drugs, sophisticated devices, and surgical procedures such as hair transplants. Overall, the market is boosted.
   
• Further, campaigns surrounding the cosmetic treatment of alopecia are more numerous these days, leading to higher adoption. Societal perceptions towards cosmetic procedures further fuel domestic marketing.
   

UK alopecia market is anticipated to witness substantial growth during 2024 to 2032 period.
 

• There is an increasing demand for improved ability to capture and service the growing market in the UK. More research and educational material combined with conveniently obtainable diagnostic services promotes revealing alopecia much sooner.
   
• Moreover, the National Health Service and NHS insurance in the UK have been more accommodating of hair loss prescriptions, letting several over-the-counter medications be used for treatment. Increased willingness to use these supplies benefits market conditions.
   

Japan holds a dominant position in the Asia Pacific alopecia market.
 

• The growing burden of the old age population triggers alopecia, a condition where one sustains hair loss at an advanced age, making it more prominent. A significant portion of the older population in Japan is suffering from alopecia due to old age and other age-associated reasons.
   
• Another important point is to stress that there is a noticeable increase in the use of cosmetic procedures and personal care services in Japan. Their shift towards enhanced physical appearance increases the consumption of both pharmaceutical and non-pharmaceutical alopecia treatments.
   

Alopecia Market Share

The market has a variety of large multinational corporations and smaller to medium-sized firms, making it a competitive market. Competitive dynamics within pharmaceutical and device manufacturing are characterized by rivalry for novel treatments which are more efficient and increasingly cheaper to produce. Innovation in this area assists in meeting the changing clinical realities of the patients and ensures improved outcomes of care, thus enabling companies to secure a significant portion of the market for advanced alopecia products.
 

Alopecia Market Companies

Some of the eminent market participants operating in the alopecia industry include:

• Apira Science, Inc. (iGROW Laser)
• Aurobindo Pharma
• Bosley – Hair Restoration & Transplant
• Cipla
• Curallux, LLC
• Dr. Reddy’s Laboratories Ltd.
• Freedom Laser Therapy, Inc. (iRESTORE Hair Growth System)
• Johnson & Johnson Services, Inc.
• Lexington International., LLC
• Merck KGaA
• Pfizer Inc.
• REVIAN, Inc.
• Smart Graft
• Sun Pharmaceuticals Industries Ltd.
• Theradome Inc.
   

Alopecia Industry News:

• In July 2024, Sun Pharmaceutical Industries Limited announced that the U.S. Food and Drug Administration (FDA) approved their LEQSELVI (deuruxolitinib) 8 mg tablets for the treatment of adults with severe alopecia. This approval increased the company’s reputation in the market, along with revenue and expansion of their product portfolio.
   
• In June 2023, Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) approved their LITFULO (ritlecitinib), a once-daily oral treatment, for individuals 12 years of age and older with severe alopecia areata. This approval enhanced Pfizer's competitiveness in the alopecia treatment market, particularly as it provided a novel option for a demographic that previously had limited treatment choices.
   

The alopecia market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 – 2032 for the following segments:

Click here to Buy Section of this Report

Market, By Disease Type

• Androgenetic alopecia
• Alopecia areata
• Other disease types 

Market, By Treatment Type

• Pharmaceuticals      
  • Topical
  • Oral
• Devices        
  • Laser cap
  • Laser comb
  • Laser helmet
• Other treatments

By Gender   

• Male   
• Female         

By Sales Channel 

• Prescription
• OTC   

By End-user

• Dermatology clinics 
• Homecare settings   
• Other end-users

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia Pacific
• Latin America
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
• Middle East and Africa
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of Middle East and Africa